TherapeuticsMD, Inc. - Common Stock (NQ:TXMD)

1.970 +0.010 (+0.51%)

Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TherapeuticsMD, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

May 31, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Hanesbrands Discloses Ransomware Attack

May 31, 2022

Incident response strategies and business continuity plans were implemented to mitigate the ransomware assault on May 24 at Hanesbrands Inc.

Via Best Stocks

Mid-Afternoon Market Update: Kirkland's Falls After Q1 Results; TherapeuticsMD Shares Climb ↗

May 31, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping 0.1% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 31, 2022

Via Benzinga

Why TherapeuticsMD Shares Are Trading Higher Today ↗

May 20, 2022

Via Benzinga

Top Gun: Maverick Puts Movie Stocks AMC, PARA, IMAX, CNK in Spotlight ↗

May 31, 2022

Top Gun: Maverick is moving movie stocks on Monday following a successful Memorial Day Weekend opening that saw it break a record.

Via InvestorPlace

Can Billionaire Nelson Peltz Save Unilever (UL) Stock? ↗

May 31, 2022

Unilever (UL) stock is a hot topic on Tuesday following news that activist investor Nelson Peltz is joining its Board of Directors.

Via InvestorPlace

Mid-Day Market Update: Nasdaq Turns Positive; Gold Fields Shares Plunge ↗

May 31, 2022

U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Tuesday.

Via Benzinga

40 Stocks Moving In Tuesday's Mid-Day Session ↗

May 31, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped 360.8% to $9.86 after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare...

Via Benzinga

Why Is TherapeuticsMD (TXMD) Stock Up 360% Today? ↗

May 31, 2022

TherapeuticsMD (TXMD) stock is rocketing higher on Tuesday following news of an acquisition deal with EW Healthcare Partners.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Dow Drops 1% ↗

May 31, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 1% on Tuesday.

Via Benzinga

TXMD Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of TherapeuticsMD, Inc. Is Fair to Shareholders

May 31, 2022

From Halper Sadeh LLP

Via Business Wire

Why TherapeuticsMD Stock Is Soaring Today ↗

May 31, 2022

TherapeuticsMD Inc (NASDAQ: TXMD) shares are surging Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 31, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 31, 2022

Welcome back and get ready because we're starting off the week with a breakdown of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

May 31, 2022

From TherapeuticsMD, Inc.

Via Business Wire

30 Stocks Moving In Monday's Mid-Day Session ↗

May 23, 2022

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 25, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...

Via Benzinga

Mid-Afternoon Market Update: Dow Dips Over 500 Points; Ross Stores Shares Slide ↗

May 20, 2022

U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping more than 500 points on Friday.

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

May 24, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Via Benzinga

Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump ↗

May 20, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday.

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

May 20, 2022

Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413.

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 24, 2022

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Deere Tops Q2 Views ↗

May 20, 2022

U.S. stocks traded higher this morning, with the Dow Jones dropping around 150 points on Friday.

Via Benzinga

66 Biggest Movers From Friday ↗

May 23, 2022

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.

Via Benzinga

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

May 20, 2022

From TherapeuticsMD, Inc.

Via Business Wire

81 Biggest Movers From Yesterday ↗

May 18, 2022

Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.

Via Benzinga

48 Stocks Moving In Tuesday's Mid-Day Session ↗

May 17, 2022

Gainers Okyo Pharma Ltd. ADR (NASDAQ: OKYO) gained 30% to $5.20 as the company priced its IPO at $4 per ADS.

Via Benzinga

TherapeuticsMD: Q1 Earnings Insights ↗

May 16, 2022

TherapeuticsMD (NASDAQ:TXMD) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TherapeuticsMD missed estimated...

Via Benzinga

TherapeuticsMD Announces First Quarter 2022 Financial Results

May 16, 2022

From TherapeuticsMD, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.